Showing results (171-180 of 181) with videos related to
Sort By:
Pageof 19
Thrombosis and Haemostasis|March 2, 1992
Double-blind, randomized comparison of systemic continuous infusion of 0.25 versus 0.50 mg/kg/24 h of alteplase over 3 to 7 days for treatment of deep venous thrombosis in heparinized patients: results of the European Thrombolysis with rt-PA in Venous Thrombosis (ETTT) trialH Bounameaux, J D Banga, E Bluhmki, et al.Journal of Vascular Surgery|October 1, 1987
Local thrombolysis in peripheral arteries and bypass graftsJ M Pernes, M de Almeida Augusto, J F Vitoux, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 11, 2000
Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Témoins de l'Infarctus du Myocarde. Paris Thrombosis case-control StudyE Arnaud, V Barbalat, V Nicaud, et al.Cardiovascular and Interventional Radiology|July 1, 1993
Infrarenal aortic stents: initial clinical experience and angiographic follow-upA L Long, J C Gaux, A C Raynaud, et al.Journal De Radiologie|May 1, 1985
[Results of in situ arterial thrombolysis by the combination of urokinase and lysyl plasminogen in acute arterial occlusive diseases of the lower limbs]J M Pernes, P Brenot, A Raynaud, et al.Clinical and Experimental Rheumatology|March 1, 1996
Anti-endothelial cell antibodies in patients with various forms of vasculitisK V Salojin, M Le Tonquèze, E L Nassovov, et al.Radiology|February 1, 1986
Acute peripheral arterial and graft occlusion: treatment with selective infusion of urokinase and lysyl plasminogenJ M Pernes, J F Vitoux, P Brenoit, et al.Journal Des Maladies Vasculaires|March 8, 2000
[Teaching targets in vascular medicine]F Becker, H Boccalon, C Boissier, et al.Thrombosis and Haemostasis|April 1, 1997
Clinical features in 36 patients homozygous for the ARG 506-->GLN factor V mutationJ Emmerich, M Alhenc-Gelas, M F Aillaud, et al.La Revue De Medecine Interne|July 1, 1989
[Treatment of deep venous thrombosis. Comparative study of a low molecular weight heparin fragment (Fragmin) by the subcutaneous route and standard heparin by the continuous intravenous route. A multicenter study]M Aiach, J N Fiessinger, J F Vitoux, et al.Pageof 19